Hospira, which makes injectable drugs and other medical products, announced that it will stop producing and shipping medicines from its Clayton, N.C facility in June.
The company reportedly will spend $15 million on severance, and some of the 250 employees losing their jobs can apply for other jobs within the company.
Hospira said costs of modernization of its plant as well as changing need for the four products made at that facility were reasons for the closure.
Read the full story
